Metabolic dysfunction-associated steatotic liver disease (MASLD) affects approximately 30% of adults, with about 30% of cases progressing to metabolic dysfunction-associated steatohepatitis (MASH), ...
Choosing between these models depends on whether you are prioritizing pure coding power, agentic autonomy, or local ...